Sputtr.com | Alternative Search Engine


The Indian Pharmaceutical Association

OM sells drugs in more than 90 countries around the world, with a focus on its four key products Broncho-Vaxo, Uro-Vaxom, Doxium and Dicynone which, Galencia believes, will boost its Vifor Pharma consumer healthcare unit.

Urinary Tract Infections: A Primer for Clinicians

Recent Advances in UTI Research Vaccines There are 2 vaccines for UTI in clinical trials in the United States including SolcoUrovac (Solco Basel, Germany) and Uro-Vaxom (OM PHARMA, Switzerland).

Public Health Safeguards in the Indian Patents Act and Review ...

Public Health Safeguards in the Indian Patents Act and Review of Mailbox Applications Society for Economic and Social Studies New Delhi In collaboration with WTO Cell, Ministry of Health & Family Welfare, Government of India and WHO India Country office, New Delhi

Treatment of Bacterial Urinary Tract Infections: Presence and ...

Uro-vaxom 1 and Strovac 1. Both preparations are recommended for patients with recurrent uncomplicated UTIs. Uro-vaxom 1 is an orally administered bacterial extract consisting of immunostimulating compo-nentsderivedfom 18 uropathogenic E. colistrains [12] .

Data and Fact 2004: German drugs in the Third World (rev2 ...

Data and Fact 2004: German drugs in the Third World (rev2 - 28 April 2005)

Oral munization

The immunomodulators Broncho-Vaxom and Uro-Vaxom stimulate the bacterial killing and oxidative metabolism of polymorphonuclear leukocytes by the activation of phosphatidyli-nositol turnover.


Urinary tract infection (UTI) continues to be among the top five reasons for consultations in health facilities nationwide. With the progressive development of new diagnostic and treatment modalities, patients are exposed to wide variations in clinical care and to potentially inappropriate and ...

Prevention of paediatric respiratory tract infections ...

(Broncho-Vaxom) for prevention of recurrent respiratory tract infections in children. Such bacterial immunostimulants are especially indicated for young infants and children who are


Gutierrez-Tarango M.D. and Berber A. Safety and effi cacy of two courses of Broncho-Vaxom in the prevention of respiratory tract infections in


oral BRONCHO-VAXOM PR: O ADULTIS BRONCHO-VAXOM PR. O : INFANTIBUS . OM-89 cryodesiccatum: Lysatum E. coli cryodesiccatum. oral URO-VAXOM. Lysatum bacteriale